Rhumbline Advisers Revolution Medicines, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

A detailed history of Rhumbline Advisers transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 251,465 shares of RVMD stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

251,465

Previous 226,992 10.78%

Holding current value

$10.2 Million

Previous $10.3 Million 6.94%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$42.97 - $60.6 $1.05 Million - $1.48 Million	24,473 Added 10.78%	251,465 $11 Million
Q3 2024 Nov 12, 2024	SELL	$36.92 - $47.94 $58,149 - $75,505	-1,575 Reduced 0.69%	226,992 $10.3 Million
Q2 2024 Aug 01, 2024	BUY	$30.14 - $40.68 $580,405 - $783,374	19,257 Added 9.2%	228,567 $8.87 Million
Q1 2024 May 09, 2024	BUY	$26.56 - $33.55 $104,965 - $132,589	3,952 Added 1.92%	209,310 $6.75 Million
Q4 2023 Feb 08, 2024	BUY	$18.35 - $34.12 $1.1 Million - $2.04 Million	59,786 Added 41.07%	205,358 $5.89 Million
Q3 2023 Nov 09, 2023	BUY	$25.17 - $35.05 $173,521 - $241,634	6,894 Added 4.97%	145,572 $4.03 Million
Q2 2023 Aug 08, 2023	BUY	$20.28 - $27.0 $106,733 - $142,101	5,263 Added 3.94%	138,678 $3.71 Million
Q1 2023 May 11, 2023	BUY	$20.76 - $30.09 $304,715 - $441,661	14,678 Added 12.36%	133,415 $2.89 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $188,026 - $271,511	10,635 Added 9.84%	118,737 $2.83 Million
Q3 2022 Nov 10, 2022	BUY	$17.46 - $26.0 $300,294 - $447,174	17,199 Added 18.92%	108,102 $2.13 Million
Q2 2022 Aug 11, 2022	BUY	$14.54 - $27.17 $217,518 - $406,463	14,960 Added 19.7%	90,903 $1.77 Million
Q1 2022 May 12, 2022	SELL	$17.31 - $26.4 $71,196 - $108,583	-4,113 Reduced 5.14%	75,943 $1.94 Million
Q4 2021 Feb 10, 2022	SELL	$24.35 - $33.7 $18,359 - $25,409	-754 Reduced 0.93%	80,056 $2.02 Million
Q3 2021 Nov 12, 2021	BUY	$23.95 - $33.41 $62,485 - $87,166	2,609 Added 3.34%	80,810 $2.22 Million
Q2 2021 Aug 05, 2021	BUY	$29.0 - $47.44 $939,803 - $1.54 Million	32,407 Added 70.77%	78,201 $2.48 Million
Q1 2021 May 06, 2021	SELL	$37.21 - $54.43 $19,832 - $29,011	-533 Reduced 1.15%	45,794 $2.1 Million
Q4 2020 Feb 10, 2021	BUY	$30.19 - $45.49 $144,881 - $218,306	4,799 Added 11.56%	46,327 $1.83 Million
Q3 2020 Nov 12, 2020	BUY	$22.61 - $34.8 $513,676 - $790,621	22,719 Added 120.79%	41,528 $1.45 Million
Q2 2020 Aug 13, 2020	BUY	$19.65 - $39.34 $88,169 - $176,518	4,487 Added 31.33%	18,809 $594,000
Q1 2020 May 06, 2020	BUY	$20.0 - $34.08 $286,440 - $488,093	14,322 New	14,322 $314,000

Others Institutions Holding RVMD

# of Institutions

298

Shares Held

181M

Call Options Held

476K

Put Options Held

864K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.57B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Revolution Medicines, Inc. Transaction History